Literature DB >> 12926159

Treatment of myxoid liposarcoma by marginal or intralesional resection combined with radiotherapy.

H Hatano1, A Ogose, T Hotta, H Kawashima, T Sugita, R Sasamoto, N Endo.   

Abstract

Local recurrence-free survival rate for myxoid liposarcoma (MLS) is related to negative surgical margins. The goal of surgery in the treatment of MLS is to obtain tumor-free surgical margins. When a tumor is adjacent to critical structures, wider resection, which can result in amputation, would be selected for local control. While recognizing that marginal or intralesional resection is associated with high risk of recurrence, circumstances occur that lead surgeons to conduct conservative surgery. To determine whether marginal or intralesional resection combined with radiotherapy can achieve local control, 10 cases (12 tumors) were reviewed involving MLS treated with marginal (8 tumors) or intralesional resection (4 tumors) followed by postoperative radiotherapy (50-70 Gy, average 59.2 Gy). No recurrences of MLS were observed locally at the mean follow-up of 58.1 months. The development of severe radiation-related complications was not detected. This medium follow-up study suggested that this method can achieve a high rate of local control.

Entities:  

Mesh:

Year:  2003        PMID: 12926159

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  Extraskeletal myxoid chondrosarcoma arising in the femoral vein: a case report.

Authors:  Naoki Oike; Akira Ogose; Hiroyuki Kawashima; Hajime Umezu; Shoichi Inagawa
Journal:  Skeletal Radiol       Date:  2014-05-13       Impact factor: 2.199

2.  A case of myxoid liposarcoma of the retroperitoneum: a challenging tumour for diagnosis and treatment.

Authors:  Emanuele Grasso; Fabio Marino; Michele Bottalico; Michele Simone
Journal:  Case Rep Surg       Date:  2014-06-12

3.  Surgical Outcomes and Prognostic Factors of Myxoid Liposarcoma in Extremities: A Retrospective Study.

Authors:  Kai Zheng; Xiu-Chun Yu; Ming Xu; Yang Yang
Journal:  Orthop Surg       Date:  2019-11-12       Impact factor: 2.071

Review 4.  Management of myxoid liposarcoma of the extremity.

Authors:  Yehia Tfayli; Ahmad Baydoun; Ahmad Salaheddine Naja; Said Saghieh
Journal:  Oncol Lett       Date:  2021-06-09       Impact factor: 2.967

5.  Myxoid liposarcoma: local relapse and metastatic pattern in 43 patients.

Authors:  Hans Roland Dürr; Jessica Rauh; Andrea Baur-Melnyk; Thomas Knösel; Lars Lindner; Falk Roeder; Volkmar Jansson; Alexander Klein
Journal:  BMC Cancer       Date:  2018-03-20       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.